Using long-read sequencing to detect and subtype a case with Temple syndrome.

Area of Science:

• Genetics
• Genomic imprinting disorders
• Epigenetics

Background:

• Temple syndrome is a rare imprinting disorder caused by genetic or epigenetic abnormalities on chromosome 14.
• Diagnosis currently involves multiple tests to detect aberrant methylation and genetic causes like maternal uniparental disomy.
• A unified diagnostic approach is needed to assess recurrence risk and physical effects.

Purpose of the Study:

• To evaluate nanopore sequencing as a single-step method for diagnosing Temple syndrome.
• To demonstrate the simultaneous detection of aberrant methylation and underlying genetic mechanisms using nanopore sequencing.
• To provide a proof of concept for a streamlined molecular diagnostic approach.

Main Methods:

• Utilized nanopore sequencing technology.
• Applied nanopore sequencing to a clinical case of Temple syndrome.
• Analyzed sequencing data to identify aberrant methylation and genetic alterations.

Main Results:

• Successfully delineated the molecular diagnosis of a Temple syndrome case using nanopore sequencing.
• Demonstrated the capability of nanopore sequencing to detect aberrant methylation simultaneously with genetic causes.
• Validated nanopore sequencing as a potential one-step diagnostic tool.

Conclusions:

• Nanopore sequencing offers a promising one-step approach for the molecular diagnosis of Temple syndrome.
• This method can simultaneously identify aberrant methylation and underlying genetic mechanisms, simplifying diagnosis.
• Further validation could establish nanopore sequencing as a valuable clinical tool for imprinting disorders.